Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pivotal Study to Validate the Usability, Safety and Diagnostic Performance of a Novel System to Non-Invasively Detect Severe Neutropenia

NCT06323447 is registered in ClinicalTrials.gov with Leuko Labs, Inc. as lead sponsor.

NCT NCT06323447
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06323447 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pivotal Study to Validate the Usability, Safety and Diagnostic Performance of a Novel System to Non-Invasively Detect Severe Neutropenia
Lead sponsor
Leuko Labs, Inc.
Phase
Observational
Overall status
Active, not recruiting
Start date
December 15, 2025
Completion date
June 30, 2027
Enrollment
210 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

diffuse large b cell lymphoma, multiple myeloma